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Abstract. Significant advances in biotechnology have allowed for simultaneous measure-
ment of molecular data points across multiple genomic and transcriptomic levels from a
single tumor/cancer sample. This has motivated systematic approaches to integrate multi-
dimensional structured datasets since cancer development and progression is driven by nu-
merous co-ordinated molecular alterations and the interactions between them. We propose
a novel two-step Bayesian approach that combines a variable selection framework with in-
tegrative structure learning between multiple sources of data. The structure learning in the
first step is accomplished through novel joint graphical models for heterogeneous (mixed
scale) data allowing for flexible incorporation of prior knowledge. This structure learning
subsequently informs the variable selection in the second step to identify groups of molecular
features within and across platforms associated with outcomes of cancer progression. The
variable selection strategy adjusts for collinearity and multiplicity, and also has theoretical
justifications. We evaluate our methods through simulations and apply them to a motivating
genomic (DNA copy number and methylation) and transcriptomic (mRNA expression) data
for assessing important markers associated with Glioblastoma progression.
Key words: Bayes variable selection; collinearity; gene networks; graph structured covariates; mixed graphical
models; prior knowledge incorporation.
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1. INTRODUCTION
The last decade has seen a proliferation of genomic data, aided partly by the rapid
evolution and declining costs of modern technologies, producing high-throughput multi-
dimensional data. It is now technologically and economically feasible to collect diverse data
on matched patient/tumor samples at a detailed molecular resolution across multiple modal-
ities such as genomics (DNA copy number and methylation), transcriptomics (mRNA/gene
expression) and proteomics. Such large scale co-ordinated efforts include worldwide con-
sortiums such as the International Cancer Genome Consortium (ICGC; icgc.org) and The
Cancer Genome Atlas (TCGA; cancergenome.nih.gov), which have collated data over mul-
tiple types of cancer on diverse molecular platforms, to accelerate discovery of molecular
markers associated with cancer development and progression.
Initial studies in cancer genomics relying on single platform analyses (mostly gene expression-
and protein-based) have discovered multiple candidate “druggable” targets such as KRAS
mutation in colon and lung cancer (Capon, et al., 1983; Shimizu, et al., 1983), BRAF in
colorectal, thyroid, and melanoma cancers (Davies, et al., 2002), and PI3K in breast, colon
and ovarian cancers (Samuels, et al., 2004; Bachman et al., 2004; Campbell et al., 2004).
However, it is believed that integrating data across multiple molecular platforms has the
potential to discover more co-ordinated changes on a global (unbiased) level (Chin et. al,
2011). Through data integration, we espouse the philosophy that cancer is driven by nu-
merous molecular/genetic alterations and the interactions between them, with each type of
alteration likely to provide a unique but complementary view of cancer progression. This of-
fers a more holistic view of the genomic landscape of cancer, with increased power and lower
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false discovery rates in detecting important biomarkers (Tyekucheva et al., 2011; Wang et.
al, 2013), and translating to substantially improved understanding, clinical management and
treatment (Hamid et. al, 2009). Integrating data across diverse platforms has sound bio-
logical justifications due to interplay between diverse genomic features. Between platforms,
attributes at the DNA level such as methylation and copy number variation can affect mRNA
expression, which in turn is known to influence clinical outcomes such as cancer progression
times and stage/pathology of the tumors. Within platform interactions arise from pathway-
based dependencies as well as dependencies based on chromosomal/genomic location (an
example being copy number data).
Statistically, the concept of data integration can be very broad depending on the scientific
question of interest such as prediction, classification, variable selection, or clustering (or
combination of these) – and is an area of active investigation. Lanckriet et al. (2004)
propose a two stage approach, first computing a kernel representation for data in each
platform and subsequently combining kernels across platforms in a classification model. Shen
et. al (2013) proposed a classification model “iCluster”, which uses a joint latent variable
model to integrate data across multiple platforms. Tyekucheva et al. (2011) propose a
logistic regression model regressing a clinical outcome on covariates across multiple platforms.
Recently Wang et al. (2013), Jennings et al (2013) proposed integrative Bayesian analysis
of genomics data (iBAG, in short), which models biological relationships between genomic
features from multiple platforms, and subsequently uses the estimated relationships to relate
the platforms to a clinical outcome. Lock et al. (2013) propose an additive decomposition
of variation approach consisting of low-rank approximations capturing joint variation across
and within platforms, while using orthogonality constraints to ensure that patterns within
3
and across platforms are unrelated.
Except for iBAG, the above approaches are not equipped to exploit the information
garnered from data integration in relating the platforms to the clinical outcome – which is
usually the goal of translational research in finding markers of cancer progression. Unfortu-
nately, iBAG assumes independence between genes in discovering mechanistic relationships
between platforms at a gene-centric level. It is well-established that genes that promote or
inhibit tumor development function in co-ordination within modules, such as functional or
cell signaling pathways (Boehm and Hahn, 2011). In this article, we propose an approach
that allows for a broad network of interactions within and between platforms (and genes)
through a graphical model approach, and subsequently ensures that associated sub-groups
of features under the estimated graph influence the outcome in a coordinated manner via a
structured variable selection step. Figure 1 provides a conceptual schematic of our approach.
Our methods are motivated by a TCGA based study focusing on discovery of impor-
tant molecular markers for progression times in glioblastoma patients by integrating diverse
platform-specific features on different scales: discrete (copy number variation) and continu-
ous (DNA methylation and mRNA expression), measured on the same set of genes. In ad-
dition, there exists substantial prior knowledge on pathway (graphical) interactions between
these genes (e.g. from databases such as KEGG, Gene Ontology or from other prior studies),
the incorporation of which can result in improved estimation and refined biological interpreta-
tions. Thus integrating information across these platforms requires us to develop a graphical
modeling approach which estimates the graph for mixed data (from different scales), while
being able to incorporate prior graphical knowledge. Different platforms might be poten-
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Figure 1: A schematic diagram of our integrative modeling approach. Panel (a) shows the heatmaps
of the genes by sample matrix constructed from data for three platforms; panel (b) depicts the prior
graph constructed using previous studies; while panel (c) is the estimated graph of the genes within
and across the platforms. The dashed arrows determine graphical structure and the solid arrows
represent the regression model incorporating graphical dependencies. Red and green lines in panel
(c) represent high negative and positive partial correlations under the estimated graph, while all
other edges with lower absolute partial correlations are depicted with watermark lines.
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tially informative about different sets of within platform gene–gene interactions which are
not evident based on single platform analysis, while clusters of features within and across
platforms are expected to work together to drive the cancer mechanism, thus rendering the
usual variable selection approaches assuming independence between covariates inadequate.
There is an increasing variable selection literature for structured covariates lying on a
known graph, which mirrors the growing recognition that incorporation of supplementary
covariate information in the analysis of genomic data can be instrumental in improved infer-
ences (Pan et al., 2010). Such developments have been aided by a proliferation of genomic
databases storing pathway and gene-gene interaction information (Stingo et. al, 2011). Some
examples of Bayesian regression and variable selection approaches for graph structured co-
variates include Li and Zhang (2010), Stingo et al. (2011), and Rockova and Lesaffre (2013).
However, the focus of the above approaches has been on single platform regression with
covariates lying on a known graph specified a priori, which is very different from the data
integration component in the present work, whereby we seek to achieve the dual goal of learn-
ing the graph for mixed covariates while incorporating prior knowledge, and subsequently
using such structure learning to relate the covariates to the outcome. We note that naively
using a fixed known graph may not be practical in genomic studies, where the network of
gene–gene interactions is likely to vary over different biological or experimental conditions.
In such cases, mis-specification of prior information can result in inferior quality inferences.
We propose a principled two stage approach which estimates the graph in the first step,
and uses this point estimate to inform the subsequent variable selection step. Concisely
stated, the major novelties presented in our article are: (i) estimating graphical models for
mixed data, while incorporating prior graphical knowledge and controlling the degree of con-
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fidence one wishes to place on the prior graph through a belief parameter. The graphical
modeling approach for mixed data models ordered categorical variables by rounding contin-
uous latent variables (Albert and Chib, 1993; Kottas, 2005; Jara et. al, 2007; Canale and
Dunson, 2012), and specifies a graphical model jointly on the observed continuous covariates
and the latent continuous variables; (ii) using the estimated graph to define (potentially
overlapping) groups of molecular features within and across platforms, which work together
in driving the outcome; and (iii) developing a structured variable selection approach, which
is designed to control collinearity by simultaneously including all variables belonging to each
aforementioned group, while having sufficient control over false positives by specifying appro-
priate multiplicity adjusted priors. The proposed approach generalizes the afore-mentioned
approaches for graph-structured covariates assuming a fixed known graph when the belief
parameter is large (≈ ∞), and corresponds to an unsupervised approach with complete lack
of prior graphical knowledge when the belief is small (≈ 0). In addition, to our knowledge,
ours is the first Bayesian graphical model approach to address mixed data.
Section 2 describes the methodology, section 3 outlines the posterior computation scheme,
section 4 provides theoretical justifications for our approach, section 5 lays out simulation
studies, section 6 applies our approach to genomic data for individuals with glioblastma
multiforme. A conclusion section summarizing the main results is provided and the Appendix
contains proof of the Theorems and posterior computation steps.
2. METHODOLOGY
Notations: In this article, we focus on a univariate continuous response, y ∈ <, to be re-
gressed on a p-dimensional vector of mixed covariates x = [x1, . . . ,xD∗ ] having an underlying
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graphical structure which is to be estimated, while incorporating prior graphical knowledge
G0. Here xj is the covariate vector corresponding to the j-th platform which has pj features,
j = 1, . . . , D∗, so that
∑D∗
j=1 pj = p. The discrete covariates (e.g. copy number) in the mixed
vector x are allowed to be binary or ordered categorical.
Let us denote the n × 1 vector of responses as Y n and the n × p dimensional covari-
ate matrix as X = [X1, . . . , XD∗ ]. We construct a joint probability model employing a
two stage strategy, and based on the factorization P (Y n, X) = P (X)P (Y n|X). In the
first structure learning stage, we use the posterior P (Ω|X,G0) ∝ P (X|Ω)P (Ω|G0) to esti-
mate the p × p precision (inverse covariance) matrix Ω for the covariates, under a con-
tinuous shrinkage prior P (Ω|G0) incorporating prior graph knowledge G0. The precision
matrix is used to obtain estimates of the graph Gˆ using a post–MCMC step as described
in the sequel. In the second step, called structured variable selection, Gˆ is used to in-
form the regression model through the prior on the model space, i.e. we specify the likeli-
hood P (Y n|X,Mγ ,ΘY |X)P (Mγ |Gˆ,ΘY |X)P (ΘY |X |Gˆ), where Mγ denotes a model in the model
space Γ and ΘY |X is the list of regression parameters. The goal of the second step is to
propose a variable selection model designed to control collinearity by incorporating the in-
formation represented by the graph structure on covariates, while having sufficient control
over multiplicity through multiplicity adjusted priors. We discuss these steps in detail below.
2.1 Integrative Structure Learning using Mixed Graphical Models
Recalling that we are dealing with mixed covariates x = [x1, . . . ,xD∗ ] across diverse plat-
forms, we propose a graphical model approach for mixed data designed to integrate and find
inherent structures within and across multiple platforms. The graphical modeling approach
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involving the vertex set V = {1, . . . , p} and edge set E, serves the following two purposes:
(1) model dependence between features within and across platforms and genes – in our ap-
plication, measurements for different platforms are available for the same set of genes, so
that the joint modeling across platforms allows for both cis-acting (localized to a gene) and
trans-acting (across gene locations) ; and subsequently (2) use the graph to detect subgroups
of features within and across platforms, as well as gene locations, which define functional
modules that are related and potentially work together to drive cancer progression. Such
modules correspond to cliques, which are defined as a subgroup of V such that each node in
this subgroup is connected to every other node in the subgroup.
The mixed data formulation: Without loss of generality, let xi = [xi1, . . . ,xiD∗ ] =
(xCi ,x
O
i ) denote the covariate vector for the i-th subject, with the superscripts C,O de-
noting continuous and ordinal (and/or binary) covariates respectively. Let zO denote the
generic notation for the latent continuous variable corresponding to ordinal predictor xO,
and consider the following graphical model for mixed covariates
xOij = l, if Dl−1 <= z
O
ij < Dl, −∞ = D0 < D1 < . . . < DMo =∞, j = 1, . . . , pO,
zOi = (z
O
i1, . . . , z
O
ipO
), (xCi , z
O
i ) ∼ N[D](0,Ω−1), Ω ∼ pi(Ω), i = 1, . . . , n, (1)
where N[D] denotes a Gaussian distribution with truncated domains for z
O, Mo is the num-
ber of ordinal levels, pO is the number of ordinal covariates, and Ω ∼ pi(Ω) corresponds to a
continuous shrinkage prior on the p × p precision matrix to be described in the sequel. To
keep things simple, the prior on the precision does not incorporate prior graphical knowledge
G0 at this stage, which is to be introduced in the next section. Instead of specifying shrinkage
priors, one can alternatively choose a discrete mixture specification (Dawid and Lauritzen,
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1993; Talluri et al., 2013) in (1) as: (xCi , z
O
i ) ∼ N[D](0,Ω−1G ), ΩG ∼ pi(Ω|G), G ∼ pi(G), i =
1, . . . , n. Such discrete mixture approaches would place exact zeros for off-diagonals with
absent edges corresponding to G, while maintaining positive definiteness of ΩG and simulta-
neously specifying a prior G ∼ pi(G). However, we adopt a continuous shrinkage approach,
as it provides us an avenue for incorporating prior knowledge in a seamless manner as well
as achieving sparsity. Under the generic continuous shrinkage specification (1), the posterior
is given by
P (Ω, zO1 , . . . , z
O
n |X) ∝ pi(Ω)
n∏
i=1

pO∏
j=1
Mo∑
l=1
1(xOij = l)1(Dl−1 ≤ zOij < Dl)
N(xCi , zOi ; 0; Ω−1),
from which MCMC samples arise. Subsequently a post-MCMC step can be implemented
in order to obtain the graph estimate Gˆ by thresholding absolute partial correlations corre-
sponding to the estimated precision matrix Ωˆ, as elaborated in Section 3.
Unfortunately, in spite of a rich literature on Gaussian graphical models, there seems to be
limited development of graphical modeling approaches incorporating prior knowledge. The
most common approach seems to be incorporating the prior graph via informative priors
on edge inclusion probabilities (Baladandayuthapani et. al, 2014), with Mukherjee and
Speed (2008) providing an alternative approach. In general, incorporating prior knowledge
for all edges through a discrete mixture approach can run in to potential difficulties, since
finite runs of the MCMC are not able to update a sizable proportion of the edges even for
moderate dimensional graphs. In such a case, these edges will not be updated at all, and
will instead correspond to the initial choice of the adjacency matrix (Kundu et al., 2014).
This violates our objective of incorporating prior knowledge while learning all possible edges
10
of the graph from the data, with such discrete mixture approaches potentially resulting in
graphical estimates which are increasingly sensitive to the initial choice of the adjacency
matrix for higher dimensions and finite lengths of MCMC chains.
The above considerations motivate us to use a continuous shrinkage approach for graph-
ical models, which is equipped to incorporate prior graphical knowledge by using a novel
procedure involving a belief parameter. Unlike discrete mixture approaches, the continuous
shrinkage based approach does not depend on an initial adjacency matrix, and can update all
elements of the precision matrix at every iteration, thus utilizing the available prior knowl-
edge on all edges to drive inferences on the graph.
2.2 Incorporating Prior Graph Information
We now describe the graphical prior incorporating prior knowledge. Let G0 be the prior
graph having vertex set V = {1, . . . , p} and edge set E0, with the corresponding adjacency
matrix A0 = (a0,ij), where a0,ij = 1 if edge (i, j) is present and 0 otherwise. Throughout this
article, we consider undirected graphs so that a0,ij = a0,ji for all (i, j). In order to incorporate
prior knowledge G0, we develop the following novel generalization of the Bayesian graphical
lasso (Wang, 2012)
pi(Ω|τ ) ∝
∏
i<j
1√
2piτij
exp(
−ω2ij
2τij
)
p∏
i=1
λii
2
exp(−λii
2
ωii)1Ω∈M+ ,
pi(τ |λ) ∝
∏
i<j
λ2ij
2
exp
(
− λ
2
ij
2
τij
)
, λij |G0 ∼ (1− pij)Ga(κij + aλ, bλ) + pijGa(aλ, bλ),
pij ∼ Be(a0,ijκij + ap, (1− a0,ij)κij + bp), (2)
where M+ is the set of positive definite matrices, λ, τ , are vectorized parameters with
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dimension p(p + 1)/2, and κij is the belief parameter for edge (i,j) (κij = κji, i 6= j, under
an undirected graph). In (2), pi(Ω|τ ) and pi(τ |λ) specifiy a double exponential prior ωij ∼
DE(λij), i 6= j and an exponential prior on the diagonals ωii ∼ Exp(λii). The novelty of
our approach involves incorporating prior knowledge G0 through the shrinkage parameter
λ via the belief parameters κ. Specification of different beliefs for different edges can be
useful when subject knowledge or historical information points strongly towards presence or
absence of certain edges (gene–gene interactions in our application), but is ambiguous about
others, as often happens in genomic studies.
Role of belief parameter: Through the use of a belief parameter, we can control the degree
of confidence we place on the available prior graph information. This is a useful feature in
enabling investigators to be flexible i.e. either skeptical or fairly confident about the prior
knowledge, thus providing them with a range of alternatives in situations where there is
reason to suspect mis-specification. To understand the role of the belief parameter in prior
specification, observe that
E(pij) = (a0,ijκij + ap)/(κij + ap + bp), E(λij) = (1− pij)(κij + aλ)/bλ + pijaλ/bλ, (3)
where i 6= j = 1, . . . , p. When a0,ij = 1 (i.e. G0 suggests presence of an edge), E(pij) ≈ 1
for large values of κij with κij >> bp. In extreme case when κij → ∞, we have pij ≈ 1
which implies E(λij) ≈ aλ/bλ ≈ 0 for appropriate values of aλ, bλ. Again for a large κij and
for a0,ij = 0 (i.e. G0 suggests absence of an edge), we have E(pij) ≈ 0. In the extreme case
when κij → ∞, we have pij ≈ 0 which implies E(λij) ≈ (κij + aλ)/bλ → ∞. In summary,
a large value of κij encourages the presence or absence of an edge through a small or large
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value of λij, according to a0,ij =1 or 0 in the prior graph. In the limiting case as κ → ∞,
the realizations under formulation (2) will become increasingly degenerate at the prior graph
G0. On the other hand when we are skeptical of the prior graph knowledge, one can simply
choose κ ≈ 0 which reduces formulation (2) to λij ∼ Ga(aλ, bλ), thus collapsing to the set-up
with no prior knowledge. These two scenarios correspond to two extremes of regression for
graph structured covariates in supervised and unsupervised settings, assuming a fixed known
graph and a complete lack of prior knowledge respectively.
Calibration of belief parameter: In practice we can use E(pij) in (3) to quantify the degree
of confidence on the presence of an edge specified by prior knowledge. On rearranging the
terms in (3) one has
κij = bp/(1− E(pij))− (ap + bp), when a0,ij = 1, κij = ap/E(pij)− (ap + bp), when a0,ij = 0.
Thus, if G0 suggests presence of the edge (i, j), and we are 50% sure of the correctness of
such prior knowledge, we can substitute E(pij) = 0.5 in the above expression to obtain κij =
bp−ap. In practice, one can choose a suitable combination of κij, ap, bp to reflect appropriate
confidence. Figure 2 presents a plot of the belief parameter versus the degree of confidence for
the scenarios when the prior graph suggests presence (a0,ij = 1) and absence (a0,ij = 0) of the
(i,j)-th edge. From the plot, one can categorize different regions of confidence: for a0,ij = 1,
low confidence corresponds to E(pij) < 0.5(−1 ≤ κij < 0), moderate confidence corresponds to
0.5 ≤ E(pij) ≤ 0.7(0 ≤ κij ≤ 1.34), and high confidence corresponds to E(pij) > 0.7(κij > 1.34).
Similar regions can also be constructed for a0,ij = 0.
2.3. Regression and Structured Variable Selection
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Figure 2: Calibration of belief parameter. The plot shows the range of the the belief parameter
(y-axis) versus degree of confidence (x-axis). The three bins demarcated by vertical blue lines
depict regions of low (−1 ≤ κ < 0), moderate (0 ≤ κ < 1.34) and high confidence (κ > 1.34) from
left to right.
Through the above steps we obtain an estimate of the graphical structure on the covariates
represented as Gˆ. In the second step, called structured variable selection, we incorporate
the structural knowledge represented by the estimated graph in regressing the outcome of
interest on covariates. Although we consider continuous outcomes, it is straightforward to
extend our approach to binary or ordinal outcomes via thresholding the latent continuous
variables (see citations in Introduction). We consider the following linear regression model
Y n = α1n + Xγβγ + , i ∼ N(0, η−1), pi(α, η) ∝ 1/η,
βγ ∼ N
(
0, gη−1(X′γXγ)
−1
)
, pi(g) =
a− 2
2
(1 + g)−
a
2 , γ ∼ pi(γ|Gˆ), i = 1, . . . , n. (4)
Here γ = {γj, j = 1, . . . , p} ∈ Γ (the model space) is the vector of variable inclusion
indicators, with γj = 1 if the jth candidate predictor is included in the model and γj = 0
otherwise, βγ is the pγ × 1 vector of the regression coefficients with pγ =
∑p
j=1 γj being the
size of model γ, Xγ is the n× pγ covariate matrix (excluding an intercept) containing the
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predictors in model γ and having the i-th row as xγ ,i, and α, η are the intercept and the
residual precision respectively. We address uncertainty in subset selection through pi(γ|Gˆ)
depending on the estimated graph structure on the covariates, while mixtures of g-prior
(Liang et al., 2008) on βγ characterizes the prior knowledge of the size of the coefficients for
the selected predictors. The tuning parameter g is assigned the hyper-g prior with a = 4.
The prior on the model space γ ∼ pi(γ|Gˆ) is defined using clique indicators. Let
C1, . . . , Cq, denote the cliques identified by the estimated graph Gˆ. The cliques are in-
dicative of (potentially overlapping) groups of associated genetic features within and across
platforms and gene locations. The variable selection approach espouses the philosophy that
features in each clique are indicative of functional modules which work in coordination to
drive the outcome. To this end, clique inclusion indicators are designed to include all fea-
tures in a clique simultaneously if that clique is significantly associated with the outcome.
Denote inclusion indicators for the k-th clique as γCk , k = 1, . . . , q. We define the prior on
the model space through clique inclusion probabilities as follows
P (γCk = 1|Gˆ) = pi, pi ∼ Be(api, bpi), (5)
where pi controls the sparsity of the model through the Beta hyperprior, with the resulting
formulation achieving multiplicity control over the selection of cliques (Scott and Berger,
2010). The above approach is designed to protect against collinearity by including a par-
ticular feature if any one of the cliques to which it belongs is significant. This implies
P (γj = 1) = P (∪k∈SjC {γCk = 1}), where S
j
C is the set of all cliques containing the j-th node.
We call the resulting approach in (4)-(5) Bayesian variable selection with structure learning
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Graphical Model Estimation
Structured Variable Selection
G0 X
λij
κij Ĝ
ap,bp pij Ck
γck pik
γj Xγ
βγ Y
η,g α
Figure 3: Directed acyclic graph of proposed model. The indices run : i 6= j = 1, . . . , p, k = 1, . . . , q,
with q being number of cliques in the estimated graph. Solid boxes, circles, dashed boxes, represent
observed data, model parameters, and model hyperparameters respectively.
(BVS-SL), a schematic representation of which is presented in Figure 3.
In practice, one can specify different inclusion probabilities pik, k = 1, . . . , q, in (5) to
account for the clique size, so as to encourage or discourage inclusion of large cliques. However
our approach is designed to produce sparse graphical estimates, so that the clique sizes are
expected be small and would not exhibit high variability, with such sparsity assumptions on
the graph being pervasive in statistical literature. The simultaneous control of collinearity
for features within cliques and multiplicity control over different cliques is designed to attain
a desirable balance between detecting true positives and true negatives, a claim which is
supported by our simulation studies.
By computing the marginal inclusion probabilities of cliques, we are in a position to
detect such subgroups which significantly affect outcome of interest. In addition, individual
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significant covariates can also be detected by computing marginal inclusion probabilities
as described previously. In the scenario when all the cliques are disjoint with q < p, the
formulation reduces to a clustering approach with all features within a certain cluster either
simultaneously included or excluded, while allowing the within cluster fixed effects to be
numerically different. In the limiting case, when each of these disjoint cliques has high
positive pair-wise correlations tending to 1, our approach reduces to the traditional clustering
approach with the within cluster fixed effects becoming numerically similar. In the special
case when q = p, the above formulation reduces to the usual stochastic search variable
selection (SSVS) approach. Finally, we demonstrate that the variable selection approach has
appealing theoretical justifications under suitable assumptions as highlighted in Section 4.
3. Posterior Computation
The proposed approach contains two distinct sets of posterior computation, one for the
graphical model estimation part, and another for the structured variable selection approach.
The graphical model estimation for mixed covariates proceeds via sampling the latent un-
derlying continuous variables corresponding to the ordered discrete covariates, followed by
drawing the joint precision matrix of (xC , zO) under formulation (2). We adapt the proce-
dure in Johnson and Albert (2001) to the case of dependent covariates, for posterior updates
of the latent continuous covariates under the following posterior distributions
zOij |xOij = l, Dl−1,j, Dl,j ∼ N(Dl−1,j ,Dl,j ](zOj |xCi , zOi (−j)), Dl,j|zOj ∼ Unif(zLl,j, zUl,j),
where zOi (−j) represents the vector of latent underlying variables for the i-th subject and
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excluding the j-th measurement, zLl,j = max
i:xOij=l
zOij and z
U
l,j = min
i:xOij=l+1
zOij for l = 1, ...,M − 1.
Once the latent variables have been updated at each MCMC iteration, we sample Ω, τ using
the method described in Wang (2012), while λij is updated by introducing an auxilary binary
variable δij ∼ Bernoulli(pij), and using the posterior
pi(λij |−) ∼ Ga(1 + aλ, |ωij |+ bλ)1(δij = 1) +Ga(1 + κij + aλ, |ωij |+ bλ)1(δij = 0),
where 1(·) is an indicator function and pij is drawn from a Beta posterior. The point
estimate of the graph is obtained as a post–MCMC step by thresholding the estimated
partial correlations. In particular, the (i,j)-th edge is included if and only if ρˆij/EW(ρij |X) >
0.5, where ρˆij is the posterior partial correlation estimate under the continuous shrinkage
approach, and EW(ρij |X) represents the posterior mean of the partial correlation under the
reference distribution W =Wishart(3, Ip). The posterior computation steps for structured
variable selection conditional on Gˆ are presented in the Appendix A.3.
4. THEORETICAL JUSTIFICATIONS
In this section, we establish variable selection and prediction consistency results for the
proposed structured variable selection approach. Model/variable selection consistency im-
plies increasing posterior probability to the true model as the sample size increases, i.e.
P (Mγ0|Y n,X)→ 1 as n→∞, where the true model in our case is given by
Mγ0 : Y
n = α+ xγ0βγ0 + , i ∼ N(0, η−1), xi ∼ N(0,Ω−10 ), i = 1, . . . , n. (6)
For prediction consistency, we would like the predicted outcome to be close to the true
expected value with increasing certainty. Given the covariate vector x∗, and the data (Y n,X),
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the predicted value as defined in Liang et. al (2008) is the optimal point estimator under
the squared error loss obtained by Bayesian model averaging
yˆ∗ = αˆ+
∑
γ∈Γ
x∗γ βˆγP (Mγ |Y n,X)
∫ ∞
0
g
1 + g
pi(g|Mγ , Y n,X)dg,
where αˆ, βˆγ are the ordinary least squares estimates for model Mγ . We call the proposed
approach consistent under prediction if P (yˆ∗ = E0(y∗)|X) → 1 as n → ∞ under the true
sampling distribution (i.e. when Mγ0 , α,βγ0 , η is known), where E0(y
∗) = α+xγ0βγ0 is the
mean in the true model. Denote MN as the null model. We have the following result under
regulatory conditions (A1)–(A3), which are presented in Appendix A.1, with the proof in
Appendix A.2.
Theorem 1 Under assumptions (A1)–(A3) and for the class of models defined by (4), model
selection consistency and prediction consistency hold under the true model Mγ0(6= MN).
5. SIMULATIONS
The goal of our simulation study is to assess the variable selection and prediction per-
formance for the proposed approach under several scenarios with varying dimensions and
association structures for the covariates. We implement the proposed approach both with-
out prior knowledge (BVS-SL) and with prior knowledge (prior corrected BVS-SL), where
the prior graph is taken to be the true graph G0 used to generate the data. The same value of
the belief parameter (50) was used for all edges corresponding to strong confidence; we also
examine the effect of varying the belief parameter as explained in the sequel. We compare the
proposed approach to stochastic search variable selection (SSVS) (George and McCullough,
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1993) assuming independence of predictors, the penalized joint credible regions approach
(PenCred) by Bondell and Reich (2012), which takes in to account dependence amongst
predictors, as well as frequentist regularization approaches such as Lasso (Tibshirani et al.,
2005) and elastic net (Zou and Hastie, 2005), using R packages ‘lars’ and ‘elasticnet’ re-
spectively. To determine the cliques for an estimated graph Gˆ under our approach, we use
the ‘igraph’ package in R. The number of MCMC iterations implemented for Bayesian ap-
proaches was 10,000, with a burn in of 3000. The training and test sample sizes were 100
each, and we consider p = 24, 40, 80. All results are reported over 20 replicates.
The data was generated from a linear regression model having p covariates out of which
nine were ordinal (generated by thresholding the continuous latent variables) and taking
values 0-4, and the rest were continuous. The true inclusion status is set to γ0j = 1, j =
1, . . . , 8, 23, 24, with four discrete variables included, and γ0j = 0 otherwise. The contin-
uous covariates and the continuous latent variables for discrete covariates were generated
using a multivariate Gaussian distribution with covariance ΣT . We consider different block-
diagonal structures for ΣT (listed hereafter), specifying subgroups of predictors with varying
partial correlations. The true graph G0 was obtained by including all edges (i, j) with
|Σ−1T (i, j)| > 0.0001.
Case I(a): This case corresponds to high partial correlations with the precision matrix
having four sub-blocks and all precision diagonals being 1. The first sub-block (4 × 4) has
off-diagonals as 0.95, the second and third sub-blocks (4×4 each) have precision off-diagonals
as 0.7, and the fourth sub-block (p− 12× p− 12) is identity. The true coefficient vector was
(0.3,−0.7, 1.1,−0.05, 0.1, 0.2,−1.2, 1.5, 0, . . . , 0, 1,−1).
Case I(b): This case corresponds to high correlations with ΣT having the same structure as
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Σ−1T in Case I(a). The coefficients were (0.3, 0.7, 1.1, 0.05,−0.1,−0.2,−1.2,−1.5, 0, . . . , 0, 1,−1).
Different signs for coefficients in cases I(a)–(b) ensures same signs for positively pair-wise
correlated covariates.
Case I(c): This case corresponds to a block diagonal with two sub-blocks - one having an
AR(1) structure for the precision matrix with Σ−1T (i, j) = 0.95
|i−j|, i, j = 1, . . . , 8, and the other
sub-block being identity. The coefficients were same as those in Case I(a).
Case I(d): This case corresponds to ΣT having the same structure as Σ
−1
T in Case I(c). The
coefficients were same as those in Case I(b).
Ordering of Models: One can obtain an ordered sequence of regression models by varying
the cut-off for the marginal inclusion probability under Bayesian approaches and varying
the penalty parameter for frequentist approaches. For each point on the ordering, we can
obtain specificity = 1- false positive rate (FPR), and sensitivity which can be considered
as the power to detect important predictors. To evaluate the ordering of the models, we
look at receiver operating characteristic (ROC ) and precision recall characteristic (PRC)
curves. For the set of ordered models, ROC curves plot sensitivity versus 1-specificity, while
PRC curves instead plot the precision (ratio of true positives to the total number declared
as positive) versus the recall or sensitivity. ROC curves present a picture of the trade-off
between type I error and power, while PRC curves give a complementary picture, examining
the trade-off between the power and false discovery rate (Davis and Goadrich, 2006).
From the ROC and PRC curves presented in the Supplementary Material, it is clear
that the curves for BVS-SL and the prior corrected BVS-SL, essentially always dominate the
competing curves for all cases in higher dimensions. The area under ROC and PRC curves
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presented in Tables 1–4 shows that the BVS-SL and prior corrected BVS-SL approaches
essentially always perform better than the competitors for all dimensions, which indicates a
superior model selection performance. From the Tables, BVS-SL demonstrates a uniformly
higher power when the false discovery rate is controlled at 10%, which points towards a
superior performance in tackling collinearity for a given multiplicity level.
Under the sample size and model dimensions we consider, the prior corrected BVS-SL
may or may not perform better than it’s uncorrected counterpart. We expect that as n
increases, the former will almost always outperform the latter for high values of the belief
parameter, under no or minimal mis-specification of the prior knowledge. Sensitivity to prior
knowledge is discussed in more detail in the sequel.
Out of Sample Prediction: In addition to looking at the ordered sequence, it is certainly of
interest to examine the predictive performance under each approach, as well as to assess the
point estimate under the optimal model. The point estimate is selected using the Bayesian
information criterion under BVS-SL, PenCred, Lasso, and elastic net, while the median
probability rule is used for SSVS. We report the model size (MS) and false positives (FP)
under the point estimate. This point estimate is also used for prediction under PenCred,
Lasso, and elastic net, while the posterior predictive distribution is used under BVS-SL and
SSVS. We look at the predictive performance in terms of out of sample mean squared error
(RMSPE) and out of sample coverage of 95% predictive intervals (COV95). The coverage
refers to the proportion of test sample values contained within predictive intervals. The
predictive intervals correspond to credible intervals for the Bayesian approaches BVS-SL
and SSVS, whereas for PenCred, as well as the frequentist approaches, they correspond to
pseudo confidence intervals that are constructed as (xβˆ − 1.96σ0,xβˆ + 1.96σ0), where σ0 is
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the true residual variance.
It is seen from Tables 1–4 that while the proposed approach has comparable performance
in terms of out of sample prediction and 95% coverage for lower dimensions, the relative
performance with respect to competitors improves significantly as the number of noise pre-
dictors is increased. The number of true covariates (MS - FP) detected under the proposed
approach, as well as the coverage, is essentially always the best or the second best among
all the approaches considered. We also see that while the SSVS might have an advantage
compared to BVS-SL in terms of controlling false positives, the prior corrected BVS-SL
essentially has similar or better multiplicity control compared to SSVS.
An important observation is that the proposed approach seems to have a distinct advan-
tage over the competitors for a large number of noise variables, a scenario often encountered
in high–dimensional genomics applications. In particular, as the number of noise variables is
increased: (i) the out of sample coverage under the proposed approach does not change sig-
nificantly, whereas the coverage for other competitors (except SSVS) decreases; and (ii) the
competing approaches (except SSVS) demonstrate the well-known multiplicity problem, reg-
istering an increasing number of false positives. On the other hand, the SSVS demonstrates
drawbacks in higher dimensions in terms of collinearity, as evidenced by smaller model sizes,
and poor power to detect true positives for a given level of false discovery.
Sensitivity to Prior Knowledge: To evaluate the sensitivity of the prior corrected BVS-
SL to prior graphical knowledge, we examined the performance when the prior knowledge
deviates from the truth. In particular, we looked at the results when the available prior
graph information has p, 2p, 3p mis-specified edges, and compared it with the scenario when
the prior graph was the truth. Our analysis indicate that (i) when the mis-specification error
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Figure 4: Plots for area under receiver operating characteristic curve and precision recall curve,
for varying belief parameters.
rate is low, the prior corrected BVS-SL has superior performance compared to BVS-SL for
high values of the belief parameter, and (ii) when the mis-specification rate is high, the prior
corrected BVS-SL can perform poorly for high values of the belief, but performs similarly
to unsupervised BVS-SL in uninformative settings involving low values of belief. This is
consistent with our expectations in the sense that we can protect against mis-specification
through low values of the belief parameter, while hoping to achieve significant improvements
through high values of the belief when the available prior graph knowledge is true or close
to the truth. In applications, we expect the belief parameter to be chosen by experts using
subject knowledge, or alternatively one can look at a series of beliefs. Figure 4 shows the
plot of area for case I(b) under the ROC and PRC curves using our approach incorporating
true prior knowledge, and a range of values of the belief parameter. It is clear that under
a true prior graph, the area under the curve for prior corrected BVS-SL is a non-decreasing
function of the belief parameter.
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6. APPLICATION TO INTEGRATIVE GENOMICS
6.1. Data Description
Our motivating dataset arises from a TCGA-based study in glioblastoma multiforme (GBM),
which is the most common and aggressive form of primary brain cancer in human adults
(Holland, 2000). The TCGA data portal (http://tcga-data.nci.nih.gov/tcga/) provides multi-
ple levels of molecular data for a large cohort of GBM tumor specimens. These specimens
underwent rigorous quality control procedures via the TCGA Biospecimen Core to ensure
high-quality DNA and RNA extraction. Each qualified specimen was assayed using multiple
assays among which we concentrate on the following: messenger RNA (mRNA) expression
using HT-HG-U133A (Affymetrix) arrays, DNA methylation (METH) using HumanMethy-
lation27K (Illumina) and DNA copy number (CN) HG-CGH-244A (Agilent) arrays. All the
resulting data from the three platforms are pre-processed, normalized and annotated to the
gene level, and referred to as Level 3 data (see Wang et al., 2013 for details). We focus our
analysis on 48 genes that overlap with the three critical signaling pathways - RTK/PI3K,
p53, and Rb, which are involved in migration, survival and apoptosis progression of cell
cycles (Furnari et al., 2007). Thus our covariate matrix consists of 48 genes mapped to these
core pathways from D∗ = 3 platforms (mRNA, METH, CN) resulting in p = 48 × 3 = 144
regressors. Note that mRNA and METH are continuous, while CN is converted into cate-
gorical via thresholding, having three categories corresponding to loss, gain, or neutral. The
outcome is log-transformed survival times for 163 uncensored patients which is regressed on
the covariates using an accelerated failure time model. An integrative study is required for
a better understanding of the interactions between these core pathways, and is expected to
25
provide new insights into the progression of GBM (Verhaak et al., 2010). A description of
our pre-processing of the copy number data is provided in the Supplementary Materials S.1.
The prior knowledge on the graphical structure between these 48 genes is based on prior
studies in GBM (Cerami et al., 2012), and is denoted as G0,pr (shown in panel (b) of Figure
1). This prior graph is obtained by assessing sequence mutations, copy number alterations
and proteins and confirm and extend the observation that GBM alterations tend to occur
within specific functional modules. Note that while the prior graph has only 48 nodes, the
graph in our analysis comprises 144 nodes, across the 3 platforms. We construct the prior
graph for these 144 nodes as one which is designed to preserve the prior graphical structure
G0,pr within the platforms, but specify null interactions between two distinct genes across
two different platforms, while assuming the presence of an edge between different platforms
at the same gene location. Thus the prior graph can be concisely written as: G0 = G0,pr⊗I3,
where ⊗ represents the Kronecker product of the two matrices.
6.2. Analysis Results
Survival Association: The marginal inclusion probabilities under our analysis are pre-
sented in Table 0.1 in Supplementary Material, with a corresponding plot in Figure 5. Since
a large number of features have inclusion probabilities greater than 0.5, we select the im-
portant features using a false discovery rate criteria controlled at a pre-specified level α, as
detailed in Appendix A.4. Under a false discovery rate threshold of α = 0.2 (corresponding
to a posterior probability threshold of 0.7), seven genes are significantly associated with pro-
gression through various mechanisms: through copy number, we have HRAS, TP53, CCND1,
BRAF and CDKN2C; through methylation, we have GRB2 and through mRNA, MDM2.
Of these CDKN2C and GRB2 are positive drivers of progression, while the remaining genes
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are negatively associated with progression. HRAS is a member of the RAS oncogene family,
whose negative effect on Glioblastoma is previously observed on the overall and progression-
free survival (Serao et al., 2011). Cyclin D1 (CCND1) belongs to the Cyclin D family of
cell cycle regulators, which are known to be up-regulated and amplified in malignant glioma
(Buschges et al., 1999). Similarly, MDM2 the inhibitor of the tumor suppressor TP53, is
established to be a candidate gene associated with short progression (Lukashchuk and Vous-
den, 2007). TP53 copy-number itself is associated with poor progression. The effect is
through the deletion of TP53, which is known be associated poor progression in GBM (Yin
et al., 2009). Although, there is no evidence of BRAF amplification in GBM, a previous
study established that BRAF amplification via gene duplication event activates the MAPK
signaling in low-grade glioma (Pfister et al., 2008). Cyclin-dependent kinase 4 inhibitor C
(CDKN2C) is a well characterized tumor suppressor gene associated with many cancers and
known to be deleted in Glioblastoma (Solomon et al., 2008; Dunn et al., 2012). On the other
hand, Growth factor receptor-bound protein 2 (GRB2) is a key protein in epidermal growth
factor receptor (EGFR and EGFRVIII) signaling in the Glioblastoma tumoroginesis path-
way (Huang et al., 2009). The positive association of progression with DNA methylation of
this gene is interesting, as it essentially inhibits the expression of this key regulator, GRB2,
in GBM.
Clique Analysis: The cliques represent groups of associated features within and across
platforms which influence the outcome in a coordinated manner. The important cliques are
detected as those having highly significant marginal inclusion probabilities P (γCj |−), j =
1, . . . , q. The clique analysis depicted multiple interesting interactions, although all the signif-
icant cliques comprise only two-way interactions. In certain cases, the multiple cliques formed
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Figure 5: Marginal inclusion probabilities for each gene over three platforms. The probabilities
are presented for the three platforms grouped by genes, with blue, red and black, implying copy
number, mRNA expression, and methylation, respectively.
with the same molecular probe with different partners have highly significant marginal in-
clusion probabilities. For instance AKT1 (METH) clique interaction with many different
molecular probes is significant (refer Table 0.2 of Supplementary Material). These cliques
constitute both tumor suppressing as well as activating interactions. The cliques involving
AKT1 (METH), PTEN (mRNA) and AKT1 (METH), PIK3R2 (mRNA) can be construed
as tumor suppressing, while cliques involving AKT1 (METH), CCND1 (mRNA) and AKT1
(METH), GRB2 (CN) probably are tumor activating. The diverse biological functionality
of the cliques represent the inherent biological subtypes with in the GBM (Verhaak et al.,
2010).
Neighborhood Analysis: In addition to detecting important markers for GBM, we also
examine the estimated graph (panel (c) of Figure 1) within and across platforms. The
degree of connectivity for nodes with marginal inclusion probabilities > 0.5 is shown in
Table 0.1 in Supplementary Materials. To further explore the biological ramifications of
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Figure 6: Neighborhood analysis of GRB2 (mRNA expression) using Ingenuity Pathway Analysis,
showing the central biological role in this molecular network as a trigger of the RAS signaling upon
the activation of upstream receptor tyrosine kinase family members.
the connectivity, the resulting neighborhood of GRB2 (mRNA) was analyzed using the
IPA (Ingenuity Systems, www.ingenuity.com) to identify the biological interactions based on
literature (Figure 6). A strong effect of DNA methylation is observed in the neighborhood
along with the mRNA, while the effect of copy number alteration is more subtle. GRB2 plays
a central biological role in this molecular network as a trigger of the RAS signaling upon
the activation of upstream receptor tyrosine kinase family members. The presence of three
important tumor suppressor genes of GBM: RB1, CDKN2B and PIK3CG is interesting,
although they have no direct interaction with GRB2. RB1 and PIK3CG seem to lose their
functionality through DNA methylation, while CDKN2B through copy number loss, enabling
the RTK/RAS activation cascade via GRB2. These events reinforce the previous illustration
in GBM that hypermethylation and deletion of RB1 and CDKN2B respectively contribute
to the loss of tumor suppressor function (Nakamura et al., 2001; Rao et al, 2010).
The partial correlations of genes between the platforms was further explored to analyze
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Figure 7: Left heatmap: hierarchical clustering of correlation between the mRNA and copy number
data; right heatmap: hierarchical clustering of correlation between the mRNA and DNA methyla-
tion data. Green and red pertains to positive and negative partial correlations respectively.
their clustering patterns so as to illustrate globally coordinated changes across platforms.
The clustered partial correlations between the genes across the platforms are visualized using
the next-generation clustering heatmaps in Figure 7. From the Figure, it is clear that there
is a enrichment of positive correlations between the mRNA and copy number data, and an
enrichment of negative correlations between the mRNA and DNA methylation data, which
further supports our biological–hypothesis driven integrative models.
7. DISCUSSION
We have proposed a novel two-step Bayesian structured variable selection approach, which
is equipped to learn the graphical structure from mixed data in the presence of prior knowl-
edge, and subsequently uses such structure learning to inform variable selection in a manner
that controls for collinearity, while having a desirable control over multiplicity. In this
paper, we focussed on integrating (more upstream) copy number, mRNA expression and
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methylation markers associated with cancer progression; however our methods can be easily
extended to account for downstream post- transcription and translational events such mi-
croRNA and proteomics markers. This will provide vital clues towards understanding the
complete genomic landscape of cancer development and progression. We leave this task for
future consideration.
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Appendix
A.1. Regulatory Conditions for Theorem 1: Let MN be the null model and let G0
now represent the true graph and not prior graphical knowledge as in the paper. Consider
the following regulatory conditions:
(A1) For any modelMγ ′ which does not contain the true model Mγ0 6= MN , limn→∞ 1nβTγ0XTγ0(I−
Pγ ′)Xγ0βγ0 = bγ
′ ∈ (0,∞), where Pγ ′ is the projection matrix on to the span of Xγ ′ .
(A2) The true graph G0 has disjoint cliques C1, . . . , Cq0 , and the true model Mγ0 (non-null)
admits the representation γ0 = ∪k∈S0{γ0j : j ∈ Ck}, for some S0 ⊆ {1, . . . , q0}.
(A3) The graphical model estimation approach is consistent, i.e. P (Gˆ = G0|X)→ 1 as n→∞.
The first assumption is a standard one in parametric consistency literature for linear
models (Liang et al., 2008). The second assumption assumes non-overlapping cliques in G0
and that the true model includes or excludes predictors belonging to a particular clique si-
multaneously. In the context of genetic studies, disjoint cliques could correspond to distinct
clusters of genes or pathways. The third assumption regarding graphical model consistency
is a strong but necessary condition. In solving the challenging problem of jointly estimating
the graphical model and the regression model, there is little hope of acheiving model selection
consistency in the second stage in the absence of a consistent graphical model approach in
the first stage. We note similar assumptions involving knowledge of the true graph structure
have been previously made in frequentist supervised clustering and feature selection litera-
ture (Shen et al. 2012).
A.2. Proof of Theorem 1: Let G denote the finite graph space. First note that
P (Mγ0 |Y n,X) =
∑
Gˆ∈G
P (Mγ0 |Y n,X, Gˆ)P (Gˆ|X)
= P (Mγ0 |Y n,X, G0)P (Gˆ = G0|X) +
∑
Gˆ∈G∩{G0}c
P (Mγ0 |Y n,X, Gˆ)P (Gˆ|X).
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For a consistent graphical model estimation approach such that P (Gˆ = G0|X) → 1, we
only need to show that P (Mγ0|Y n,X, G0) → 1 as n → ∞ for model selection consistency.
Similarly, it is clear that the predicted value under assumption (A3) can be expressed as
yˆ∗ = αˆ+
∑
γ∈Γ
∑
G∈G
P (G|X)x∗γ βˆγP (Mγ |Y n,X, G)
∫ ∞
0
g
1 + g
pi(g|Mγ , Y n,X)dg
≈ αˆ+
∑
γ∈Γ
x∗γ βˆγP (Mγ |Y n,X, G0)
∫ ∞
0
g
1 + g
pi(g|Mγ , Y n,X)dg for large n.
Let C1, . . . , Cq0 be the disjoint cliques corresponding to the true graph G0. Under our ap-
proach, the posterior probabilities P (Mγ |Y n,X) ≈ P (Mγ |Y n,X, G0) as n → ∞, will only be
positive for models belonging to Γ∗ = {γ : γ = ∪k∈S∗{γ0j : j ∈ Ck, ∀S∗ ⊆ {1, . . . , q0}}, so that
the true model Mγ0 defined in (6) and assumption (A2) belongs to Γ
∗. The proof of the
variable selection consistency follows by Theorem 3 of Liang et. al (2008) by using clique
indicators γCj , j = 1, . . . , q0 in place of variable inclusion indicators in their article. The proof
for prediction consistency follows using variable selection consistency and using Theorem 4
of Liang et. al (2008).
A.3. Posterior Computation Steps for Variable Selection
The computation strategy described in section 3 yields an estimate of the graph, which is
used to inform the variable selection approach in the second step as described here. At a
particular MCMC iteration, let γ+(j) denote the vector of current variable inclusion indica-
tors having γk = 1 for all k ∈ Cj, and similarly denote γ−(j) as the vector of current variable
inclusion indicators having γk = 0 for all k ∈ Cj. Further let pj+, pj− denote the model sizes
corresponding to γ+j ,γ
−
j respectively. The Gibbs sampling alternates as follows
Step 1: Sample γCj ∼ Ber(
p+j
p+j +p
−
j
), j = 1, . . . , p, where
p+j =
a− 2
pj+ + a− 22F1
(
n− 1
2
, 1;
pj+ + a
2
; R2γ+j
)
, p−j =
a− 2
pj− + a− 22F1
(
n− 1
2
, 1;
pj− + a
2
; R2γ−j
)
,
with 2F1(a, b; c; z) =
Γ(c)
Γ(b)Γ(c− b)
∫ 1
0
tb−1(1− t)c−b−1
(1− tz)a dt,
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with 2F1(·) being the Gaussian hypergeometric function (computed using the ‘BAS’ package in R),
R2γ is the ordinary coefficient of determination of regression model, and q is the number of cliques.
Step 2: Sample fixed effects using pi(βγ |−) = N
(
g
1+g (X
T
γXγ)
−1XTγY n,
g
1+g
(XTγXγ)
−1
η
)
.
Step 3: Sample the residual precision using pi(η|−) = Ga(n/2 + aη,
∑
i
(Y n − Xγ+βγ+)T (Y n −
Xγ+βγ+)/2 + bη).
Step 4: Sample clique prior inclusion probabilities using f(pi|−) = Beta(q∗+api, q−q∗+bpi) , where
q∗ is the number of cliques selected using Step 1.
Step 5: Sample g using the fact that a hyper-g prior on g with a = 4 is equivalent to a uni-
form prior on g′, where g′ = g1+g . For sampling g
′, we use a discretized grid of 1000 grids point
from 0.01 to 0.999 with the posterior probability for grid-point g∗ being computed as pi(g′|−) ∝(
g′
1−g′
)− pγ
2
exp
{
− η2g′/(1−g′)βTγ (XTγXγ)βγ
}
. We then use the transformation g = g
′
1−g′ to obtain g.
A.4. FDR based Criteria for Inclusion: We briefly discuss the FDR based criteria
used in section 6.2 to determine the cut-off on posterior probabilities, as described in Bal-
adandayuthapani et al. (2010). In particular, we can choose a threshold φα for posterior
probabilities so as to control the average Bayesian FDR at level α, which essentially implies
that we expect 100α% of the significant markers to be false positives. To obtain such an
estimate, first sort the posterior probabilities for all markers in ascending order to yield
pr(j), j = 1, . . . , p. Then φα = pr(ζ), where ζ = max
{
j∗ : j∗−1
∑j∗
j=1 pr(ζ) ≤ α
}
.
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Table 1: Simulations for Case I(a), training sample size = 100, test sample size = 100.
p=24
Method MSPE ROC PRC Pwr(10% FDR) MS FP Cov95
BVS-SL 1.102 0.998 0.999 1.000 10.368 0.474 0.923
Prior Corr BVS-SL (κ = 20) 1.101 1.000 1.000 1.000 10.250 0.250 0.923
PenCred 1.122 0.915 0.926 0.833 8.200 0.450 0.914
SSVS 1.107 0.960 0.957 0.895 8.200 0.300 0.924
Lasso 1.157 0.892 0.907 0.815 11.400 2.700 0.912
EL 1.165 0.899 0.911 0.820 11.600 2.850 0.910
p=40
BVS-SL 1.103 0.997 0.996 1.000 10.000 0.444 0.922
Prior Corr BVS-SL (κ = 20) 1.100 1.000 1.000 1.000 10.250 0.250 0.921
PenCred 1.153 0.890 0.869 0.802 9.400 1.700 0.912
SSVS 1.123 0.954 0.921 0.880 7.650 0.200 0.917
Lasso 1.206 0.894 0.870 0.815 10.950 2.900 0.893
EL 1.218 0.906 0.874 0.815 11.150 3.050 0.893
p=80
BVS-SL 1.093 0.999 0.996 1.000 9.800 0.250 0.928
Prior Corr BVS-SL (κ = 20) 1.092 1.000 1.000 1.000 10.600 0.600 0.930
PenCred 1.270 0.888 0.790 0.740 13.700 6.150 0.880
SSVS 1.128 0.965 0.897 0.895 8.050 0.750 0.926
Lasso 1.288 0.879 0.770 0.800 10.700 3.100 0.883
EL 1.300 0.890 0.773 0.790 11.050 3.450 0.879
MSPE: out of sample predictive MSE; Pwr(10% FDR) is sensitivity controlling for 90% specificity; MS:
estimated model size; FP: false positives, and Cov95 is coverage under 95% predictive intervals.
Table 2: Simulations for Case I(b), training sample size = 100, test sample size = 100.
p=24
Method MSPE ROC PRC Pwr(10% FDR) MS FP Cov95
BVS-SL 1.055 0.962 0.964 0.950 7.850 0.150 0.939
Prior Corr BVS-SL (κ = 20) 1.055 0.969 0.976 0.950 8.450 0.050 0.940
PenCred 1.057 0.770 0.802 0.565 5.600 0.250 0.942
SSVS 1.052 0.820 0.842 0.645 6.000 0.200 0.941
Lasso 1.168 0.618 0.677 0.450 7.200 2.300 0.907
EL 1.175 0.638 0.693 0.460 7.300 2.300 0.905
p=40
BVS-SL 1.108 0.971 0.947 0.955 9.100 1.000 0.924
Prior Corr BVS-SL (κ = 20) 1.111 0.987 0.981 0.985 9.550 0.650 0.923
PenCred 1.156 0.749 0.679 0.550 6.200 1.200 0.912
SSVS 1.107 0.842 0.785 0.695 6.400 0.650 0.925
Lasso 1.251 0.630 0.563 0.423 8.650 4.050 0.885
EL 1.265 0.648 0.598 0.465 8.300 3.450 0.881
p=80
BVS-SL 1.089 0.960 0.927 0.950 8.200 0.500 0.922
Prior Corr BVS-SL (κ = 20) 1.082 0.975 0.963 0.965 8.600 0.400 0.927
PenCred 1.212 0.738 0.561 0.518 9.450 4.450 0.888
SSVS 1.093 0.863 0.730 0.725 6.050 0.600 0.924
Lasso 1.290 0.609 0.473 0.450 6.100 2.200 0.861
EL 1.295 0.628 0.536 0.530 7.250 2.750 0.861
MSPE: out of sample predictive MSE; Pwr(10% FDR) is sensitivity controlling for 90% specificity; MS:
estimated model size; FP: false positives, and Cov95 is coverage under 95% predictive intervals.
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Table 3: Simulations for Case I(c), training sample size = 100, test sample size = 100.
p=24
Method MSPE ROC PRC Pwr(10% FDR) MS FP Cov95
BVS-SL 1.070 0.958 0.941 0.905 7.789 0.421 0.923
Prior Corr BVS-SL (κ = 20) 1.068 0.981 0.978 0.975 7.800 0.250 0.925
PenCred 1.090 0.856 0.897 0.750 7.450 0.400 0.922
SSVS 1.080 0.873 0.899 0.780 7.200 0.300 0.923
Lasso 1.109 0.852 0.822 0.760 10.450 2.450 0.914
EL 1.101 0.885 0.903 0.810 10.400 2.150 0.915
p=40
BVS-SL 1.071 0.969 0.929 0.965 7.941 0.529 0.936
Prior Corr BVS-SL (κ = 20) 1.066 0.986 0.978 0.980 8.000 0.100 0.936
PenCred 1.118 0.879 0.860 0.780 9.150 1.750 0.921
SSVS 1.086 0.880 0.894 0.825 7.150 0.250 0.932
Lasso 1.142 0.857 0.787 0.808 11.550 3.550 0.918
EL 1.145 0.895 0.847 0.820 11.250 2.950 0.917
p=80
BVS-SL 1.092 0.951 0.927 0.935 8.000 0.316 0.928
Prior Corr BVS-SL (κ = 20) 1.084 0.992 0.988 0.990 7.650 0.050 0.928
PenCred 1.253 0.867 0.770 0.735 12.650 5.750 0.889
SSVS 1.109 0.895 0.796 0.745 6.600 0.200 0.921
Lasso 1.179 0.814 0.729 0.695 10.650 3.800 0.909
EL 1.189 0.861 0.770 0.738 9.900 3.100 0.910
MSPE: out of sample predictive MSE; Pwr(10% FDR) is sensitivity controlling for 90% specificity; MS:
estimated model size; FP: false positives, and Cov95 is coverage under 95% predictive intervals.
Table 4: Simulations for Case I(d), training sample size = 100, test sample size = 100.
p=24
Method MSPE ROC PRC Pwr(10% FDR) MS FP Cov95
BVS-SL 1.068 0.839 0.846 0.675 6.650 0.500 0.930
Prior Corr BVS-SL (κ = 20) 1.066 0.823 0.845 0.705 6.350 0.450 0.931
PenCred 1.086 0.745 0.770 0.557 5.800 0.850 0.923
SSVS 1.065 0.810 0.810 0.560 5.800 0.500 0.932
Lasso 1.159 0.551 0.606 0.348 6.450 2.650 0.906
EL 1.167 0.576 0.633 0.353 5.700 1.950 0.906
p=40
BVS-SL 1.072 0.922 0.851 0.845 6.850 0.850 0.934
Prior Corr BVS-SL (κ = 20) 1.065 0.893 0.857 0.825 6.250 0.400 0.935
PenCred 1.126 0.691 0.622 0.480 6.450 1.700 0.915
SSVS 1.071 0.855 0.767 0.645 5.500 0.500 0.933
Lasso 1.218 0.556 0.475 0.340 5.000 1.750 0.891
EL 1.225 0.594 0.516 0.390 5.100 1.550 0.893
p=80
BVS-SL 1.109 0.937 0.788 0.865 5.900 0.900 0.919
Prior Corr BVS-SL (κ = 20) 1.105 0.894 0.798 0.815 5.800 0.400 0.918
PenCred 1.226 0.633 0.419 0.358 7.850 4.150 0.897
SSVS 1.124 0.840 0.655 0.628 4.600 0.400 0.914
Lasso 1.239 0.509 0.354 0.320 4.650 1.700 0.886
EL 1.248 0.596 0.406 0.355 4.800 1.700 0.881
MSPE: out of sample predictive MSE; Pwr(10% FDR) is sensitivity controlling for 90% specificity; MS:
estimated model size; FP: false positives; Cov95: coverage under 95% predictive intervals.
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